HF
VERA icon

HRT Financial’s Vera Therapeutics VERA Stock Holding History

HRT Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-40,851
Closed -$1.19M – 4102
2025
Q3 		$1.19M Buy
+40,851
New +$945K ﹤0.01% 1435
2024
Q4 		– Sell
-32,239
Closed -$1.42M – 3305
2024
Q3 		$1.42M Sell
32,239
-6,091
-16% -$231K 0.01% 1040
2024
Q2 		$1.39M Buy
+38,330
New +$1.52M 0.01% 868

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

HRT Financial's VERA Position: Q4 2025 in Review

HRT Financial sold out of Vera Therapeutics (VERA) in Q4 2025, closing a stake of 40,851 shares — an estimated $1.19M sold.

HRT Financial first reported a position in VERA in Q2 2024 and held it in 3 quarters. The position peaked at $1.42M in Q3 2024. 214 funds tracked by Wall St. Rank hold VERA as of Q4 2025.

  • HRT Financial reported no remaining Vera Therapeutics position as of Q4 2025 after selling out during the quarter.
  • HRT Financial sold 40,851 Vera Therapeutics shares in Q4 2025, an estimated $1.19M.
  • HRT Financial first reported a position in Vera Therapeutics in Q2 2024 and held it in 3 quarters.
  • HRT Financial's Vera Therapeutics position peaked at $1.42M in Q3 2024.
  • 214 funds tracked by Wall St. Rank held Vera Therapeutics as of Q4 2025.

Based on HRT Financial's 13F filing for Q4 2025, filed 12 Feb 2026.